MedPath

昆山培力药品有限公司

Ownership
-
Established
1995-03-02
Employees
-
Market Cap
-
Website
http://kspeili.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H32021474
Approval Date
Aug 21, 2020
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H32021473
Approval Date
Aug 21, 2020
NMPA

Diclofenac Potassium Suppositories

Product Name
普他宁
Approval Number
国药准字H20040193
Approval Date
Aug 21, 2020
NMPA

Econazole Nitrate Suppositories.

Product Name
硝酸益康唑栓
Approval Number
国药准字H32021475
Approval Date
Aug 21, 2020
NMPA

Diclofenac Potassium Suppositories

Product Name
双氯芬酸钾栓
Approval Number
国药准字H20061251
Approval Date
Aug 21, 2020
NMPA

Metformin Hydrochloride and Glibenclamide Tablets(Ⅰ)

Product Name
二甲双胍格列本脲片(Ⅰ)
Approval Number
国药准字H20080804
Approval Date
Dec 11, 2018
NMPA

Clindamycin Phosphate Suppositories

Product Name
克林霉素磷酸酯栓
Approval Number
国药准字H20080810
Approval Date
Dec 10, 2018
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.